...
首页> 外文期刊>Journal of Dispersion Science and Technology >Process Optimization, Characterization, and Release Study In Vitro of an Intravenous Puerarin Lipid Micropheres Loaded with the Phospholipid Complex
【24h】

Process Optimization, Characterization, and Release Study In Vitro of an Intravenous Puerarin Lipid Micropheres Loaded with the Phospholipid Complex

机译:负载磷脂复合物的静脉注射葛根素脂质微球的工艺优化,表征和释放研究

获取原文
获取原文并翻译 | 示例
           

摘要

A new formulation of puerarin lipid microspheres with the puerarin-phospholipid complex was prepared. A central composite design approach was used for process optimization in order to obtain the acceptable puerarin-phospholipid complex. The physicochemical properties of the complex obtained by optimal parameters were investigated by Fourier transform infrared spectrophotometry (FTIS). The physicochemical characterizations of puerarin lipid microspheres was evaluated. The release study in vitro of puerarin was studied by using microdialysis and pressure ultrafiltration technology. Multiple linear regression analysis for process optimization revealed that the acceptable puerarin-phospholipid complex was obtained wherein the optimal values of X1, X2, and X3 were 3, 60°C, and 3 hours, respectively. The FTIS studies of the complex demonstrated that puerarin and phospholipids were combined by non-covalent bonds, not form new compounds. The mean diameter and entrapment efficiency (%) were 171.35 and 87.94, respectively. The release of puerarin lipid microspheres could be evaluated by using microdialysis and ultrafiltration, but microdialysis seemed to be more suitable for the release study of puerarin lipid spheres. The drug release at three drug concentrations was initially rapid, but reached a plateau value within 30 minutes. Drug release of puerarin from the lipid microspheres occurred via burst release.View full textDownload full textKeywordsCharacterization, lipid microspheres, phospholipid complex, process optimizationRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/01932690903543600
机译:制备了具有葛根素-磷脂复合物的葛根素脂质微球的新制剂。为了获得可接受的葛根素-磷脂复合物,使用了中央复合设计方法来优化工艺。通过傅里叶变换红外分光光度法(FTIS)研究了通过最佳参数获得的配合物的理化性质。评价了葛根素脂质微球的理化特性。利用微透析和压力超滤技术研究了葛根素的体外释放研究。用于过程优化的多元线性回归分析表明,获得了可接受的葛根素-磷脂复合物,其中X 1 ,X 2 和X 3 分别是3、60°C和3小时。 FTIS对复合物的研究表明,葛根素和磷脂是通过非共价键结合的,而不是形成新化合物。平均直径和截留效率(%)分别为171.35和87.94。葛根素脂质微球的释放可以通过微透析和超滤来评估,但微透析似乎更适合于葛根素脂质球的释放研究。最初在三种药物浓度下的药物释放较快,但在30分钟内达到稳定值。葛根素从脂质微球的药物释放通过爆发释放发生。 ,delicious,linkedin,facebook,stumbleupon,digg,google,more“,发布编号:” ra-4dff56cd6bb1830b“};添加到收藏夹链接永久链接http://dx.doi.org/10.1080/01932690903543600

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号